Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride

Tang,Shi‑Hang; Gao,Jin‑Hang; Wen,Shi‑Lei; Tong,Huan; Yan,Zhao‑Ping; Liu,Rui; Tang,Cheng‑Wei

doi:10.3892/mmr.2017.6161

Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride

Authors:
- Shi‑Hang Tang
- Jin‑Hang Gao
- Shi‑Lei Wen
- Huan Tong
- Zhao‑Ping Yan
- Rui Liu
- Cheng‑Wei Tang
View Affiliations

Affiliations: Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Human Anatomy, Academy of Preclinical and Forensic Medicine, West China Medicine College, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: February 2, 2017 https://doi.org/10.3892/mmr.2017.6161
Pages: 1507-1512
Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple long non-coding RNAs (lncRNAs) have been demonstrated to be involved in liver disease. Increased cyclooxygenase-2 (COX‑2) levels have also been reported to be involved in the progression of liver cirrhosis. In the present study, the correlations between lncRNA‑COX‑2 RNA expression levels, COX‑2 mRNA expression levels and liver fibrosis were examined. Liver fibrosis was induced by intraperitoneal injection of carbon tetrachloride (CCl4) in mice for 2 months (CCl4‑2M) or 3 months (CCl4‑3M). Liver histopathological evaluation was conducted using hematoxylin and eosin and Masson trichrome staining. Hepatic expression of COX‑2 and lncRNA‑COX‑2 was evaluated by reverse transcription‑quantitative polymerase chain reaction and immunohistochemical staining. Compared with the control group, fibrotic areas were increased four and nine times in the CCl4‑2M group and the CCl4‑3M group, respectively. LncRNA-COX-2 and COX‑2 upregulation were observed in the cirrhotic liver. COX‑2 mRNA expression levels and lncRNA-COX-2 RNA expression levels were significantly positively correlated with the fibrotic area. In addition, COX‑2 mRNA expression was significantly positively correlated with lncRNA‑COX‑2 expression. These results suggest that expression of COX‑2 and lncRNA‑COX‑2 increased with the progression of liver fibrosis. LncRNA-COX-2 may potentially be considered as a novel therapeutic target for liver fibrosis.

View Figures

View References

1	Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
2	Fallowfield JA: Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 300:G709–G715. 2011. View Article : Google Scholar : PubMed/NCBI
3	Olson JC and Saeian K: Gastrointestinal issues in liver disease. Crit Care Clin. 32:371–384. 2016. View Article : Google Scholar : PubMed/NCBI
4	Pazirandeh S, Khettry U, Gordon FD, Resnick RH, Murray JE and Sheth SG: Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States. Dig Dis Sci. 52:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
5	Simmons DL, Botting RM and Hla T: Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 56:387–437. 2004. View Article : Google Scholar : PubMed/NCBI
6	Jeong SW, Jang JY, Lee SH, Kim SG, Cheon YK, Kim YS, Cho YD, Kim HS, Lee JS, Jin SY, et al: Increased expression of cyclooxygenase-2 is associated with the progression to cirrhosis. Korean J Intern Med. 25:364–371. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhou JY, Jiang ZA, Zhao CY, Zhen Z, Wang W and Nanji AA: Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res. 37:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
8	Gao JH, Wen SL, Yang WJ, Lu YY, Tong H, Huang ZY, Liu ZX and Tang CW: Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS One. 8:e693092013. View Article : Google Scholar : PubMed/NCBI
9	Wen SL, Gao JH, Yang WJ, Lu YY, Tong H, Huang ZY, Liu ZX and Tang CW: Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. J Gastroenterol Hepatol. 29:1932–1942. 2014. View Article : Google Scholar : PubMed/NCBI
10	Yu J, Hui AY, Chu ES, Go MY, Cheung KF, Wu CW, Chan HL and Sung JJ: The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats. Liver Int. 29:25–36. 2009. View Article : Google Scholar : PubMed/NCBI
11	Holt AP and Adams DH: Complex roles of cyclo-oxygenase 2 in hepatitis. Gut. 56:903–904. 2007. View Article : Google Scholar : PubMed/NCBI
12	Peng W and Fan H: Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma. Biomed Pharmacother. 72:113–118. 2015. View Article : Google Scholar : PubMed/NCBI
13	Hung T and Chang HY: Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585. 2010. View Article : Google Scholar : PubMed/NCBI
14	Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, et al: A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 472:120–124. 2011. View Article : Google Scholar : PubMed/NCBI
15	Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al: lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
16	Mourtada-Maarabouni M, Hedge VL, Kirkham L, Farzaneh F and Williams GT: Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J Cell Sci. 121:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang B, Li BS and Yang SM: The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett. 360:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
18	Sun J, Bie B, Zhang S, Yang J and Li Z: Long non-coding RNAs: Critical players in hepatocellular carcinoma. Int J Mol Sci. 15:20434–20448. 2014. View Article : Google Scholar : PubMed/NCBI
19	Tong Q, Gong AY, Zhang XT, Lin C, Ma S, Chen J, Hu G and Chen XM: LincRNA-Cox2 modulates TNF-α-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRD-mediated epigenetic histone modifications. FASEB J. 30:1187–1197. 2016. View Article : Google Scholar : PubMed/NCBI
20	Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB, et al: A long noncoding RNA mediates both activation and repression of immune response genes. Science. 341:789–792. 2013. View Article : Google Scholar : PubMed/NCBI
21	Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu J, Wang DS, Song WJ and Dou KF: Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma. Int J Biol Sci. 10:664–676. 2014. View Article : Google Scholar : PubMed/NCBI
22	He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu BM, Xu FY, Zhang L, Lv XW and Li J: Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochim Biophys Acta. 1842:2204–2215. 2014. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011. View Article : Google Scholar : PubMed/NCBI
25	Giannitrapani L, Ingrao S, Soresi M, Florena AM, La Spada E, Sandonato L, D'Alessandro N, Cervello M and Montalto G: Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: An immunohistochemical study. Ann N Y Acad Sci. 1155:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
26	Mohammed NA, Abd E, l-Aleem SA, El-Hafiz HA and McMahon RF: Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: A possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol. 57:350–400. 2004. View Article : Google Scholar : PubMed/NCBI
27	Zhao Y, Wang Y, Wang Q, Liu Z, Liu Q and Deng X: Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway. Mol Cell Biochem. 359:217–223. 2012. View Article : Google Scholar : PubMed/NCBI
28	Sacerdoti D, Pesce P, Di Pascoli M, Brocco S, Cecchetto L and Bolognesi M: Arachidonic acid metabolites and endothelial dysfunction of portal hypertension. Prostaglandins Other Lipid Mediat. 120:80–90. 2015. View Article : Google Scholar : PubMed/NCBI
29	Hu H, Jing X, Zou X and Wu J: Role of cyclooxygenase 2 and its inhibitor valdecoxib in liver fibrosis. Zhonghua Yi Xue Za Zhi. 94:784–787. 2014.(In Chinese). PubMed/NCBI
30	He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
31	Yoon JH, Abdelmohsen K and Gorospe M: Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
32	Kitagawa M, Kotake Y and Ohhata T: Long non-coding RNAs involved in cancer development and cell fate determination. Curr Drug Targets. 13:1616–1621. 2012. View Article : Google Scholar : PubMed/NCBI
33	Wang F, Xie C, Zhao W, Deng Z, Yang H and Fang Q: Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Clin Exp Med. Oct 3–2015.(Epub ahead of print).
34	Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 29:1810–1816. 2012. View Article : Google Scholar : PubMed/NCBI
35	Rouzer CA and Marnett LJ: Cyclooxygenases: Structural and functional insights. J Lipid Res. 50(50 Suppl): S29–S34. 2009.PubMed/NCBI
36	Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE, Gentilini P and Marra F: Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology. 33:713–721. 2001. View Article : Google Scholar : PubMed/NCBI
37	Hui AY, Cheng AS, Chan HL, Go MY, Chan FK, Sakata R, Ueno T, Sata M and Sung JJ: Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line. Prostaglandins Leukot Essent Fatty Acids. 71:329–333. 2004. View Article : Google Scholar : PubMed/NCBI
38	Kawada N: Evolution of hepatic fibrosis research. Hepatol Res. 41:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
39	Matsui M, Chu Y, Zhang H, Gagnon KT, Shaikh S, Kuchimanchi S, Manoharan M, Corey DR and Janowski BA: Promoter RNA links transcriptional regulation of inflammatory pathway genes. Nucleic Acids Res. 41:10086–10109. 2013. View Article : Google Scholar : PubMed/NCBI
40	Krawczyk M and Emerson BM: p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-αB complexes. Life. 3:e017762014.